Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model

Archives of Toxicology

Volumn 85, Issue 2, 2011, Pages 155-162

  Dewa, Yasuaki ^a,b   Nishimura, Jihei ^a,b   Jin, Meilan ^c   Kawai, Masaomi ^a,b   Saegusa, Yukie ^a,b   Kenmochi, Sayaka ^a,b   Shimamoto, Keisuke ^a,b   Harada, Tomoaki ^a   Shibutani, Makoto ^a   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Apoptosis; Cell proliferation; Cyp1a enzyme induction; Hepatocarcinogenesis; Oxfendazole; Oxidative stress

Indexed keywords

ALDO KETO REDUCTASE 7; AROMATIC HYDROCARBON RECEPTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLINE; CYTOCHROME P450 1A1; DIETHYLNITROSAMINE; GLUTATHIONE PEROXIDASE 2; OXFENDAZOLE; OXIDOREDUCTASE; PROTEIN P21; SINGLE STRANDED DNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; FOOD INTAKE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT;

ADENOMA, LIVER CELL; ANIMALS; ANTHELMINTICS; APOPTOSIS; BENZIMIDAZOLES; CARCINOGENS; CELL CYCLE PROTEINS; CELL PROLIFERATION; COCARCINOGENESIS; DIETHYLNITROSAMINE; DNA, SINGLE-STRANDED; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344;

ANIMALIA; RATTUS;

EID: 79954444357     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-010-0557-1     Document Type: Article

References (29)

1. Bock KW, Köhle C (2005) Ah receptor-and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem Pharmacol 69:1403-1408 (Pubitemid 40602440)
2. Bock KW, Köhle C (2006) Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 72:393-404 (Pubitemid 44061741)
3. Buchmann A, Kuhlmann W, Schwarz M, Kunz W, Wolf CR, Moll E, Friedberg T, Oesch F (1985) Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis 6:513-521 (Pubitemid 15101779)
4. Buchmann A, Bock KW, Schwarz M (1992) Enzyme and immunohistochemical phenotyping of diethylnitrosamine-induced liver lesions of male C3H/He, B6C3F1 and C57BL/6J mice. Carcinogenesis 13:691-697
5. Cameron R, Sweeney GD, Jones K, Lee G, Farber e (1976) A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo (a) pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Res 36:3888-3893
6. Chu FF, Esworthy RS Doroshow JH (2004) Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic Biol Med 36:1481-1495 (Pubitemid 38746557)
7. Dewa Y, Nishimura J, Muguruma M, Matsumoto S, Takahashi M, Jin M, Mitsumori K (2007) Gene expression analyses of the liver in rats treated with oxfendazole. Arch Toxicol 81:647-654 (Pubitemid 47228767)
8. Dewa Y, Nishimura J, Muguruma M, Jin M, Kawai M, Saegusa Y, Okamura T, Umemura T, Mitsumori K (2009) Involvement of oxidative stress in hepatocellular tumor-promoting activity of oxfendazole in rats. Arch Toxicol 83:503-511
9. El-Makawy A, Radwan HA, Ghaly IS, El-Raouf AA (2006) Genotoxical teratological and biochemical effects of anthelmintic drug oxfendazole Maximum Residue Limit (MRL) in male and female mice. Reprod Nutr Dev 46:139-156 (Pubitemid 43667346)
10. Farber e (1990) Clonal adaptation during carcinogenesis. Biochem Pharmacol 39:1837-1846 (Pubitemid 20187316)
11. Grasl-Kraupp B, Ruttkay-Nedecky B, Müllauer L, Taper H, Huber W, Bursch W, Schulte-Hermann R (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25:906-912 (Pubitemid 27157133)
12. Gudas JM, Hankinson O (1987) Regulation of cytochrome P-450c in differentiated and dedifferentiated rat hepatoma cells: role of the Ah receptor. Somat Cell Mol Genet 13:513-528
13. Harris TE, Albrecht JH, Nakanishi M, Darlington GJ (2001) CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J Biol Chem 276:29200-29209
14. Hayes JD, Judah DJ, Neal GE (1993) Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehydecontaining metabolite of the toxin. Cancer Res 53:3887-3894 (Pubitemid 23267683)
15. Hines RN, Luo Z, Cresteil T, Ding X, Prough RA, Fitzpatrick JL, Ripp SL, Falkner KC, Ge NL, Levine A, Elferink CJ (2001) Molecular regulation of genes encoding xenobiotic-metabolizing enzymes: mechanisms involving endogenous factors. Drug Metab Dispos 29:623-633 (Pubitemid 32374561)
16. Ireland LS, Harrison DJ, Neal GE, Hayes JD (1998) Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase. Biochem J 332:21-34
17. Ito N, Tamano S, Shirai T (2003) A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci 94:3-8 (Pubitemid 36575850)
18. Jacobs DEJ, Taylor MA (2001) Drugs used in the treatment and control of parasitic infections. In: Bishop J (ed) The veterinary formulary, 5th edn. Pharmaceutical Press, London, pp 219-245
19. Judah DJ, Hayes JD, Yang JC, Lian LY, Roberts GC, Farmer PB, Lamb JH, Neal GE (1993) A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant. Biochem J 292:13-18 (Pubitemid 23158954)
20. Mitsumori K, Onodera H, Shoda T, Uneyama C, Imazawa T, Takegawa K, Yasuhara K, Watanabe T, Takahashi M (1997) Liver tumour-promoting effects of oxfendazole in rats. Food Chem Toxicol 35:799-806 (Pubitemid 27417763)
21. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59:65-85
22. Nishimura J, Dewa Y, Okamura T, Jin M, Saegusa Y, Kawai M, Umemura T, Shibutani M, Mitsumori K (2008) Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats. Toxicol Sci 106:339-349
23. Rowlands JC, Gustafsson JA (1997) Aryl hydrocarbon receptormediated signal transduction. Crit Rev Toxicol 27:109-134 (Pubitemid 27158455)
24. Shoda T, Onodera H, Takeda M, Uneyama C, Imazawa T, Takegawa K, Yasuhara K, Watanabe T, Hirose M, Mitsumori K (1999) Liver tumor promoting effects of fenbendazole in rats. Toxicol Pathol 27:553-562 (Pubitemid 29446824)
25. Tan EH, Hooi SC, Laban M, Wong E, Ponniah S, Wee A, Wang ND (2005) CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Cancer Res 65:10330-10337 (Pubitemid 41743726)
26. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ (1996) CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 10:804-815
27. Velik J, Baliharova V, Fink-Gremmels J, Bull S, Lamka J, Skalova L (2004) Benzimidazole drugs and modulation of biotransformation enzymes. Res Vet Sci 76:95-108 (Pubitemid 38258192)
28. WHO (1991) Residues of some veterinary drugs in animals and foods. Monographs prepared by the thirty-eighths meeting of the joint FAO/WHO Expert Committee on food additives. FAO Food Nutr Pap 41:1-136
29. WHO (1999) Evaluation of certain veterinary drug residues in food. Fiftieth report of the joint FAO/WHO Expert Committee on Food Additives. World Health Organ. Tech Rep Ser 888:1-95